申请人:Board of Regents, The University of Texas System
公开号:US20210094921A1
公开(公告)日:2021-04-01
Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.
本文披露了抑制RIPK1的化合物、制药组合物以及治疗RIPK1介导的疾病(如神经退行性疾病、炎症性疾病和癌症)的方法。